SynSimPred: Leveraging Cell Line Similarities for Drug Combination Synergy Prediction

preprint OA: closed CC-BY-4.0
📄 Open PDF Full text JSON View at publisher
AI-generated deep summary by claude@2026-07, 2026-07-06 · read from full text

This preprint presents SynSimPred, a computational method for predicting drug combination synergy scores using features derived from cancer cell lines, including cell line similarities, gene expression, mutations, dependencies, and copy number variations, and it applies multiple regression approaches to model their relationship to drug efficacy. The authors report a case study in which SynSimPred predicts synergistic and antagonistic interactions for example drug pairs (Vinblastine with Veliparib, and Deforolimus with Dactolisib). SynSimPred is evaluated against existing methods (DeepSynergy, HypergraphSynergy, and SynPred) on two datasets, O’NEIL and ALMANAC, using metrics such as MSE, Precision, F-Measure, and Accuracy, where it is reported to outperform prior models. The paper does not state specific limitations in the provided text beyond noting it is a preprint that has not been peer reviewed. The paper does not explicitly discuss endometriosis or adenomyosis; it was included in the corpus via a keyword match in the upstream search index.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Abstract Cancer treatment faces significant challenges, necessitating innovative approaches to predict and enhance drug efficacy. Computational models, particularly advanced machine learning methods, have shown promise in customizing drug response predictions and improving patient outcomes. However, predicting synergistic drug combinations remains complex due to the vast number of potential interactions and the limitations of both data availability and traditional research methodologies. In response, our study introduces SynSimPred, a computational approach that leverages cell line similarities, gene expression, mutations, dependencies, and copy number variations to predict drug synergy scores. SynSimPred employs a suite of sophisticated regression methodologies to navigate the complex interplay between these biological characteristics and their impact on drug efficacy. A key component of our research involved a detailed case study where SynSimPred predicted the synergistic and antagonistic interactions of drug pairs such as Vinblastine and Veliparib, and Deforolimus and Dactolisib, demonstrating its practical utility and accuracy in real-world scenarios. We rigorously evaluated SynSimPred against leading methods including DeepSynergy, HypergraphSynergy, and SynPred, across two comprehensive datasets, O'NEIL and ALMANAC. Our evaluations, using metrics such as MSE, Precision, F-Measure, and Accuracy, demonstrate that SynSimPred consistently outperforms existing models, establishing it as a frontrunner in the field of predictive methodologies for cancer treatment.
Full text 11,342 characters · extracted from preprint-html · click to expand
SynSimPred: Leveraging Cell Line Similarities for Drug Combination Synergy Prediction | Research Square window.SnipcartSettings = { analytics: { enabled: false } }; (function() { var accessVector = localStorage.getItem('access_vector') || ''; window.dataLayer = window.dataLayer || []; if (accessVector) { window.dataLayer.push({ user: { profile: { profileInfo: { snid: accessVector } } } }); } })(); (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src='https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-K279D39R'); Browse Preprints In Review Journals COVID-19 Preprints AJE Video Bytes Research Tools Research Promotion AJE Professional Editing AJE Rubriq About Preprint Platform In Review Editorial Policies Our Team Advisory Board Help Center Sign In Submit a Preprint Cite Share Download PDF Article SynSimPred: Leveraging Cell Line Similarities for Drug Combination Synergy Prediction Soodabeh Zakeri, Fatemeh Yassaee Meybodi, Changiz Eslahchi This is a preprint; it has not been peer reviewed by a journal. https://doi.org/ 10.21203/rs.3.rs-4589706/v1 This work is licensed under a CC BY 4.0 License Status: Posted Version 1 posted You are reading this latest preprint version Abstract Cancer treatment faces significant challenges, necessitating innovative approaches to predict and enhance drug efficacy. Computational models, particularly advanced machine learning methods, have shown promise in customizing drug response predictions and improving patient outcomes. However, predicting synergistic drug combinations remains complex due to the vast number of potential interactions and the limitations of both data availability and traditional research methodologies. In response, our study introduces SynSimPred, a computational approach that leverages cell line similarities, gene expression, mutations, dependencies, and copy number variations to predict drug synergy scores. SynSimPred employs a suite of sophisticated regression methodologies to navigate the complex interplay between these biological characteristics and their impact on drug efficacy. A key component of our research involved a detailed case study where SynSimPred predicted the synergistic and antagonistic interactions of drug pairs such as Vinblastine and Veliparib, and Deforolimus and Dactolisib, demonstrating its practical utility and accuracy in real-world scenarios. We rigorously evaluated SynSimPred against leading methods including DeepSynergy, HypergraphSynergy, and SynPred, across two comprehensive datasets, O'NEIL and ALMANAC. Our evaluations, using metrics such as MSE, Precision, F-Measure, and Accuracy, demonstrate that SynSimPred consistently outperforms existing models, establishing it as a frontrunner in the field of predictive methodologies for cancer treatment. Biological sciences/Computational biology and bioinformatics/Computational models Biological sciences/Computational biology and bioinformatics/Data integration Biological sciences/Computational biology and bioinformatics/Machine learning Drug combination Cancer Synergy Therapeutic efficacy Full Text Additional Declarations No competing interests reported. Cite Share Download PDF Status: Posted Version 1 posted You are reading this latest preprint version Research Square lets you share your work early, gain feedback from the community, and start making changes to your manuscript prior to peer review in a journal. As a division of Research Square Company, we’re committed to making research communication faster, fairer, and more useful. We do this by developing innovative software and high quality services for the global research community. Our growing team is made up of researchers and industry professionals working together to solve the most critical problems facing scientific publishing. Also discoverable on Platform About Our Team In Review Editorial Policies Advisory Board Help Center Resources Author Services Accessibility API Access RSS feed Manage Cookie Preferences © Research Square 2026 | ISSN 2693-5015 (online) Privacy Policy Terms of Service Do Not Sell My Personal Information {"props":{"pageProps":{"initialData":{"identity":"rs-4589706","acceptedTermsAndConditions":true,"allowDirectSubmit":true,"archivedVersions":[],"articleType":"Article","associatedPublications":[],"authors":[{"id":321382656,"identity":"a2ddd07a-f69f-4215-b2fa-54be1ef036a7","order_by":0,"name":"Soodabeh Zakeri","email":"","orcid":"","institution":"School of Biological Sciences, Institute for Research in Fundamental Sciences","correspondingAuthor":false,"prefix":"","firstName":"Soodabeh","middleName":"","lastName":"Zakeri","suffix":""},{"id":321382657,"identity":"f09d0eff-c316-4c01-be68-8b15aba38985","order_by":1,"name":"Fatemeh Yassaee Meybodi","email":"","orcid":"","institution":"School of Biological Sciences, Institute for Research in Fundamental Sciences","correspondingAuthor":false,"prefix":"","firstName":"Fatemeh","middleName":"Yassaee","lastName":"Meybodi","suffix":""},{"id":321382658,"identity":"25e62915-fd8a-4590-966b-8c6a92ed2c74","order_by":2,"name":"Changiz Eslahchi","email":"data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAZAAAAAyAQMAAABI0h/eAAAABlBMVEX///8AAABVwtN+AAAACXBIWXMAAA7EAAAOxAGVKw4bAAAA5ElEQVRIie3RsWrCQBzH8d8R0OVC1j8E7Cv8xbHgs9zh4KYtXSwdjATS0TXgSzg6Jtzgcg8Q0EEfIUtJttqUToVTN4f7Dv/h4MP/Dwf4fI8Y/YwXKJBYnUTy+1hcJ9yRlO8l6NEfcRZtEnFueDyLNmn23u4Mos9CmIVrybEIRpInb3Qss0NoDcgqlNZBmOZfMTjQW9LZQWQGqIDSdSCT6rcNLzvy2l7I0w2kB8mmIwgvhK8RqlQQS97rvNJpHNqpHFqdOEmUK1E3iw+9zqfnut09DwZ7Y2oX+ZcEbvodn8/n87n6BjNLTvwpgJZtAAAAAElFTkSuQmCC","orcid":"","institution":"Shahid Beheshti University","correspondingAuthor":true,"prefix":"","firstName":"Changiz","middleName":"","lastName":"Eslahchi","suffix":""}],"badges":[],"createdAt":"2024-06-16 12:36:11","currentVersionCode":1,"declarations":"","doi":"10.21203/rs.3.rs-4589706/v1","doiUrl":"https://doi.org/10.21203/rs.3.rs-4589706/v1","draftVersion":[],"editorialEvents":[],"editorialNote":"","failedWorkflow":false,"files":[{"id":64435739,"identity":"a3409166-24f6-48df-9fbe-7409980d0487","added_by":"auto","created_at":"2024-09-13 07:07:56","extension":"pdf","order_by":1,"title":"","display":"","copyAsset":false,"role":"manuscript-pdf","size":349052,"visible":true,"origin":"","legend":"","description":"","filename":"SynSimPred.pdf","url":"https://assets-eu.researchsquare.com/files/rs-4589706/v1_covered_8f3e297a-57ec-445d-bf6c-aa5408556e57.pdf"}],"financialInterests":"No competing interests reported.","formattedTitle":"SynSimPred: Leveraging Cell Line Similarities for Drug Combination Synergy Prediction","fulltext":[],"fulltextSource":"","fullText":"","funders":[],"hasAdminPriorityOnWorkflow":false,"hasManuscriptDocX":false,"hasOptedInToPreprint":true,"hasPassedJournalQc":"","hasAnyPriority":false,"hideJournal":true,"highlight":"","institution":"","isAcceptedByJournal":false,"isAuthorSuppliedPdf":true,"isDeskRejected":"","isHiddenFromSearch":false,"isInQc":false,"isInWorkflow":false,"isPdf":true,"isPdfUpToDate":true,"isWithdrawnOrRetracted":false,"journal":{"display":true,"email":"[email protected]","identity":"researchsquare","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":true,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"/submission","title":"Research Square","twitterHandle":"researchsquare","acdcEnabled":true,"dfaEnabled":false,"editorialSystem":"","reportingPortfolio":"","inReviewEnabled":false,"inReviewRevisionsEnabled":true},"keywords":"Drug combination, Cancer, Synergy, Therapeutic efficacy","lastPublishedDoi":"10.21203/rs.3.rs-4589706/v1","lastPublishedDoiUrl":"https://doi.org/10.21203/rs.3.rs-4589706/v1","license":{"name":"CC BY 4.0","url":"https://creativecommons.org/licenses/by/4.0/"},"manuscriptAbstract":"Cancer treatment faces significant challenges, necessitating innovative approaches to predict and enhance drug efficacy. Computational models, particularly advanced machine learning methods, have shown promise in customizing drug response predictions and improving patient outcomes. However, predicting synergistic drug combinations remains complex due to the vast number of potential interactions and the limitations of both data availability and traditional research methodologies. In response, our study introduces SynSimPred, a computational approach that leverages cell line similarities, gene expression, mutations, dependencies, and copy number variations to predict drug synergy scores. SynSimPred employs a suite of sophisticated regression methodologies to navigate the complex interplay between these biological characteristics and their impact on drug efficacy. A key component of our research involved a detailed case study where SynSimPred predicted the synergistic and antagonistic interactions of drug pairs such as Vinblastine and Veliparib, and Deforolimus and Dactolisib, demonstrating its practical utility and accuracy in real-world scenarios. We rigorously evaluated SynSimPred against leading methods including DeepSynergy, HypergraphSynergy, and SynPred, across two comprehensive datasets, O'NEIL and ALMANAC. Our evaluations, using metrics such as MSE, Precision, F-Measure, and Accuracy, demonstrate that SynSimPred consistently outperforms existing models, establishing it as a frontrunner in the field of predictive methodologies for cancer treatment.","manuscriptTitle":"SynSimPred: Leveraging Cell Line Similarities for Drug Combination Synergy Prediction","msid":"","msnumber":"","nonDraftVersions":[{"code":1,"date":"2024-07-03 04:28:35","doi":"10.21203/rs.3.rs-4589706/v1","editorialEvents":[{"type":"communityComments","content":0}],"status":"published","journal":{"display":true,"email":"[email protected]","identity":"researchsquare","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":true,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"/submission","title":"Research Square","twitterHandle":"researchsquare","acdcEnabled":true,"dfaEnabled":false,"editorialSystem":"","reportingPortfolio":"","inReviewEnabled":false,"inReviewRevisionsEnabled":true}}],"origin":"","ownerIdentity":"d2dd3dd2-bee9-477f-8007-1bb9d3d3fdfb","owner":[],"postedDate":"July 3rd, 2024","published":true,"recentEditorialEvents":[],"rejectedJournal":[],"revision":"","amendment":"","status":"posted","subjectAreas":[{"id":33978315,"name":"Biological sciences/Computational biology and bioinformatics/Computational models"},{"id":33978316,"name":"Biological sciences/Computational biology and bioinformatics/Data integration"},{"id":33978317,"name":"Biological sciences/Computational biology and bioinformatics/Machine learning"}],"tags":[],"updatedAt":"2024-09-13T06:59:49+00:00","versionOfRecord":[],"versionCreatedAt":"2024-07-03 04:28:35","video":"","vorDoi":"","vorDoiUrl":"","workflowStages":[]},"version":"v1","identity":"rs-4589706","journalConfig":"researchsquare"},"__N_SSP":true},"page":"/article/[identity]/[[...version]]","query":{"redirect":"/article/rs-4589706","identity":"rs-4589706","version":["v1"]},"buildId":"8U1c8b4HqxoKbykW_rLl7","isFallback":false,"isExperimentalCompile":false,"dynamicIds":[84888],"gssp":true,"scriptLoader":[]}

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: preprint-html

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2024) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-05-20T01:45:00.602351+00:00
unpaywall
last seen: 2026-05-30T02:00:01.510937+00:00
License: CC-BY-4.0